Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
255
天
Durable Responses and Cystectomy Avoidance With Interleukin-15 Receptor Agonist NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer With Carcinoma In Situ ± Papillary Disease
作者
Sam S. Chang; Karim Chamie; Charles A. Seabury; Mark L. Gonzalgo; Piyush Kumar Agarwal; Jeffrey C. Bassett; Marc Bjurlin; Michael L. Cher; William Clark; Barrett E. Cowan; Richard David; Evan Goldfischer; Khurshid Guru; Mark W. Jalkut; Samuel D. Kaffenberger; Jed Kaminetsky; Anthony Corcoran; Alec S. Koo; Wade J. Sexton; Sergei N. Tikhonenkov; Mihir S. Shah; Edouard J. Trabulsi; Andrew F. Trainer; Patricia Spilman; Leylah M. Drusbosky; Bruce Brown; Megan Huang; Paul Bhar; Lennie Sender; Sandeep Reddy; Patrick Soon-Shiong展开收起
作者单位
1. Department of Urology, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; 2. Department of Urology, UCLA Medical Center, Los Angeles, California; 3. Virginia Urology, Richmond, Virginia; 4. Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, Florida; 5. Department of Surgery, Section of Urology, University of Chicago, Chicago, Illinois; 6. Hoag Urologic Oncology, Hoag Memorial Presbyterian Hospital, Newport Beach, California; 7. Department of Urology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 8. Department of Urology, Wayne State University, Detroit, Michigan; 9. Karmanos Cancer Center, Detroit, Michigan; 10. Alaska Urological Institute, Soldotna, Alaska; 11. Urology Associates, Englewood, Colorado; 12. Genesis Healthcare Partners, Greater Los Angeles Division, Sherman Oaks, California; 13. Premier Medical Group, Poughkeepsie, New York; 14. Roswell Park Comprehensive Cancer Center, Buffalo, New York; 15. Associated Urologists of North Carolina, Raleigh, North Carolina; 16. Department of Urology, University of Michigan, Ann Arbor, Michigan; 17. University Urology, New York, New York; 18. NYU Winthrop Hospital, Garden City, New York; 19. Genesis Healthcare Partners, Torrance, California; 20. Moffitt Cancer Center, Tampa, Florida; 21. University of Hawaii Cancer Center, Honolulu, Hawaii; 22. Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania; 23. Jefferson Einstein Medical Center, Philadelphia, Pennsylvania; 24. Adult and Pediatric Urology, Omaha, Nebraska; 25. ImmunityBio, Culver City, California展开收起
104
天
Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI
作者
Jeffrey J. Tosoian; Jacob I. Meyers; Bradley Moore; Cameron J. Britton; Kent Chevli; Walter Rayford; Adam J. Gadzinski; Jean V. Joseph; Pratik Patel; Ali Kasraeian; Prithipal S. Sethi; Hunter S. Robinson; Keavash D. Assani; Vijay Rings; Janene Pierce; Kristen R. Scarpato; Kelvin A. Moses; Daniel A. Barocas; Sam S. Chang; David F. Penson; Martin G. Sanda; Ashley E. Ross; Matthew R. Cooperberg; Keyan Salari; Michael Liss; Yuping Zhang; Javed Siddiqui; Udit Singhal; Simpa S. Salami; Todd M. Morgan; Ganesh S. Palapattu; John T. Wei; Jingyi Cao; Vikram Bala; Younggook Oh; Spencer Heaton; Yingye Zheng; Arul M. Chinnaiyan展开收起
作者单位
1. Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee; 2. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; 3. Lynx Dx, Ann Arbor, Michigan; 4. Western New York Urology Associates, Cheektowaga, New York; 5. The Urology Group, Memphis, Tennessee; 6. Comprehensive Urology, Royal Oak, Michigan; 7. Department of Urology, University of Rochester Medical Center, Rochester, New York; 8. Arizona State Urological Institute (ASUI) and Arizona State Urological Research Institute (ASURI), Gilbert, Arizona; 9. Kasraeian Urology, Jacksonville, Florida; 10. Golden State Urology, Sacramento, California; 11. Geisinger Medical Center, Department of Urology, Danville, Pennsylvania; 12. Department of Urology, Emory University School of Medicine, Atlanta, Georgia; 13. Northwestern University Department of Urology, Chicago, Illinois; 14. University of California San Francisco Departments of Urology and Epidemiology & Biostatistics, San Francisco, California; 15. Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; 16. Department of Urology, UC San Diego Health, San Diego, California; 17. Department of Pathology, University of Michigan, Ann Arbor, Michigan; 18. Department of Urology, University of Michigan, Ann Arbor, Michigan; 19. Rogel Cancer Center, Ann Arbor, Michigan; 20. Fred Hutchinson Cancer Research Center, Seattle, Washington; 21. Howard Hughes Medical Institute, Chevy Chase, Maryland展开收起
194
天
Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study
作者
Cindy L. Amundsen; Suzette E. Sutherland; John P. F. A. Heesakkers; Philip Toozs-Hobson; Frank Martens; Rebecca J. McCrery; Kevin Benson; Kevin J. Cline; Peter R. Rodine; Roger R. Dmochowski展开收起
作者单位
1. Department of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery, Duke University, Durham, North Carolina; 2. Pelvic Health Center, Arizona Urology Specialists, Scottsdale, Arizona; 3. Department of Urology, Maastricht UMC, Maastricht, the Netherlands; 4. Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom; 5. Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; 6. Adult Pediatric Urology and Urogynecology, Ohama, Nebraska; 7. Department of Obstetrics and Gynecology, FPMRS Division, Sanford Health, University of South Dakota School of Medicine, Sioux Falls, South Dakota; 8. Louisiana State University Medical Center, Shreveport, Louisiana; 9. BlueWind Medical Inc., Salt Lake City, Utah展开收起
164
天
UGN-102 for Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
作者
Sandip M. Prasad; Dimitar Shishkov; Nikola Vladimirov Mihaylov; Pencho Genov; Vasyl Terzi; Max Kates; William C. Huang; Michael J. Louie; Brent Burger; Andrew Meads; Mark Schoenberg展开收起
作者单位
1. Morristown Medical Center/Atlantic Health System and Garden State Urology, Morristown, New Jersey; 2. Department of Urology, University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria; 3. Department of Urology, University Multiprofile Hospital for Active Treatment “Kanev,” Ruse, Bulgaria; 4. Multiprofile Hospital for Active Treatment, Part of the Military Medical Academy, Varna, Bulgaria; 5. The Johns Hopkins Medical Institutions, Baltimore, Maryland; 6. NYU Langone Urology Associates, New York, New York; 7. UroGen Pharma, Princeton, New Jersey; 8. The Department of Urology, Montefiore Einstein, Bronx, New York展开收起
140
天
12-Month Outcomes From a Randomized, Sham-Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia
作者
Steven A. Kaplan; Sijo J. Parekattil; Ning Z. Wu; Brian Mazzarella; Michael Trotter; Sheldon Freedman; Samuel Lawindy; Raviender Bukkapatnam; Bradley F. Schwartz; Barry Jones; Prithipal Sethi; Mark Jalkut; John S. Liu; Dean Elterman; Edward Gheiler; Ricardo R. Gonzalez; Jed Kaminetsky; Jay A. Motola; Alexis Te; Christopher Chapple; Lori Lerner; Thomas Lynch展开收起
作者单位
1. Icahn School of Medicine at Mount Sinai, New York, New York; 2. Avant Concierge Urology, Winter Garden, Florida; 3. Comprehensive Urologic Care, Lake Barrington, Illinois; 4. Urology Austin, Austin, Texas; 5. Midtown Urology Associates, Austin, Texas; 6. Freedman Urology, Las Vegas, Nevada; 7. Advanced Urology Institute, Daytona Beach, Florida; 8. Florida Urology Partners, Tampa, Florida; 9. SIU Medicine, Springfield, Illinois; 10. St James’s Hospital, Dublin, Ireland; 11. Golden State Urology, Stockton, California; 12. Associated Urologists of North Carolina, Raleigh, North Carolina; 13. Urology of Virginia, Virginia Beach, Virginia; 14. Division of Urology, University of Toronto, Toronto, Ontario, Canada; 15. Urology Specialist Group, Miami, Florida; 16. Houston Methodist Hospital, Houston, Texas; 17. Advanced Urology Centers of New York, New York, New York; 18. NYU Langone Health, New York, New York; 19. Sheffield Teaching Hospitals NHS Foundation, Sheffield, United Kingdom; 20. Boston University School of Medicine, Boston, Massachusetts展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天